Serving International Diagnostic Manufacturers
NeoMark Ventures has direct experience working with manufacturers from across the global diagnostics industry. We understand the commercial, regulatory, and cultural differences that shape how international companies approach the U.S. market — and we bridge them.
Why International Manufacturers Choose NeoMark Ventures
The U.S. diagnostics market is unlike any other. Its regulatory framework, reimbursement structure, laboratory purchasing dynamics, and competitive landscape require a partner with genuine, on-the-ground experience — not a generalist consultant. International manufacturers choose NeoMark Ventures because we combine deep U.S. market knowledge with a proven track record of working across global diagnostic industries.
Who We Work With
We work with established diagnostic manufacturers and innovative technology companies that have promising clinical products and are seeking experienced U.S. commercialization support.
Whether your company is evaluating the U.S. market for the first time or seeking to strengthen an existing commercial presence, NeoMark Ventures can help identify opportunities and develop a practical path forward.
Precision Engineering Meets U.S. Market Complexity
European diagnostic manufacturers — particularly from Germany, Switzerland, France, the Netherlands, and the UK — bring world-class engineering and rigorous quality standards to the U.S. market. NeoMark Ventures helps European manufacturers translate CE-marked technologies into FDA-cleared U.S. products, navigate the significant differences between European and U.S. reimbursement systems, and build the commercial relationships needed to compete in the world's largest diagnostics market.
Germany, Switzerland, France, UK, Netherlands, and beyond
CE mark to FDA clearance pathway coordination
European vs. U.S. reimbursement system navigation
Established relationships with European IVD manufacturers
Innovation Leadership in Immunoassay and Molecular Diagnostics
Japan is home to some of the world's most innovative diagnostic manufacturers, with particular strength in immunoassay platforms, molecular diagnostics, and precision analytical instruments. NeoMark Ventures has direct experience working with Japanese manufacturers navigating the cultural and commercial differences between the Japanese and U.S. markets — from regulatory strategy and distributor selection to the relationship-building practices that are essential to U.S. commercial success.
Immunoassay, molecular diagnostics, and analytical instruments
Cultural and commercial bridge between Japanese and U.S. markets
PMDA to FDA regulatory pathway coordination
Long-term relationship development with U.S. laboratory partners
Emerging Technology Manufacturers Entering the U.S. Market
Taiwan's diagnostic technology sector has grown significantly in recent years, with manufacturers developing competitive rapid diagnostic, point-of-care, and molecular testing platforms. NeoMark Ventures helps Taiwanese manufacturers build credibility in the U.S. market, identify the right commercial partners, and develop the regulatory and reimbursement strategies needed to compete against established global players.
Rapid diagnostic, point-of-care, and molecular testing platforms
U.S. market credibility and brand development
Commercial partner identification and qualification
Regulatory strategy for emerging market entrants
Rapid Growth in IVD and Biomarker Technologies
South Korea has emerged as a significant force in the global IVD industry, with manufacturers demonstrating particular strength in rapid testing, biomarker platforms, and next-generation molecular diagnostics. NeoMark Ventures works with South Korean manufacturers to develop U.S. market-entry strategies that capitalize on their technological strengths while addressing the specific commercial and regulatory requirements of the U.S. market.
Rapid testing, biomarker platforms, and molecular diagnostics
U.S. market-entry strategy for high-growth IVD companies
FDA clearance and CMS reimbursement coordination
Distribution and laboratory partner development
Singapore, Israel, Canada, and Beyond
NeoMark Ventures works with innovative diagnostic manufacturers from across the global industry. Whether your company is based in Singapore, Israel, Canada, Australia, or another market, we bring the same depth of U.S. market knowledge and hands-on commercial support to every engagement. If you have a differentiated diagnostic technology and are serious about the U.S. market, we want to hear from you.
Singapore, Israel, Canada, Australia, and other markets
Technology-agnostic approach to U.S. market entry
Consistent process regardless of country of origin
Open to any manufacturer with a differentiated technology
What Sets Us Apart
Real U.S. Market Experience
We have spent decades in the U.S. clinical diagnostics industry — not as consultants observing from the outside, but as commercial executives building businesses and introducing new technologies.
Established Relationships
Our network spans clinical reference laboratories, hospital systems, specialty distributors, and key opinion leaders across the U.S. diagnostics ecosystem. These relationships take years to build — our clients benefit from them immediately.
International Track Record
We have direct experience working with manufacturers from Europe, Asia, and the Pacific Rim. We understand the differences in business culture, regulatory frameworks, and commercial expectations — and we bridge them effectively.
Is Your Technology Ready for the U.S. Market?
Contact NeoMark Ventures to discuss your technology and explore whether we are the right U.S. commercial partner for your market entry.